Urinary levels of monocyte chemoattractant protein 1 (MCP-1) and liver-type fatty acid-binding protein (L-FABP) did not differ between the TAC–AKI and non-AKI groups before or after tacrolimus administration. The gene discussed is CCL2; the disease is persistent truncus arteriosus.